Biogen Inc. ? will present new data from its felzartamab clinical development programs at Kidney Week 2025, the American Society of Nephrology's (ASN) annual meeting, taking place November 5-9 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback